Found 10 matching trials
Effects of Single Dose Citalopram and Reboxetine on Urethral and Anal Closure Function on Healthy Female Subjects
PHASE1This study will investigate if citalopram, a selective serotonin reuptake i...
Location
Department of Clinical Pharmacology, Bispebjerg and Frederiksberg Hospital
Interaction Between Reboxetine and 3,4-Methylenedioxymethamphetamine: Pharmacodynamics (PD) and Pharmacokinetics (PK)
PHASE1MDMA releases dopamine, serotonin, and norepinephrine in the brain. Seroton...
Location
University Hospital
A Comparison of Sertraline-reboxetine Combination Therapy Versus Sertraline or Reboxetine Monotherapy in the Treatment of Major Depression.
PHASE2This study was designed to determine if the novel combination of the SSRI, ...
Location
Pfizer Investigational Site
Cognitive Flexibility in Major Depression in the Course of Pharmacological and Psychotherapeutic Treatment
NACognitive deficits in major depression seem explicable by the well-recogniz...
Location
Zentrum für Integrative Psychiatrie
The Role of the Brain in Mental and Physical Fatigue
PHASE3The goal of this clinical trial is to determine the role of brain neurotran...
Location
Brussels Labo voor Inspanning & Topsport U-residence
The Role of Dopaminergic and Noradrenergic Neurotransmission in Value- and Salience-based Decision-Making
NAApproach versus avoidance decisions are at the centre of adaptive behaviour...
Location
University of Zurich
Efficacy of Hydroxyzine for Patients With Panic Disorder
PHASE4The aim of this study is to evaluate the efficacy of hydroxyzine compared t...
Location
Multiple Locations
Open Label Extension Study of [S,S]-Reboxetine in Patients With Fibromyalgia
PHASE3This is a study to investigate the long-term safety and effectiveness \[S,S...
Location
Pfizer Investigational Site
Effect of Escitalopram vs. Reboxetine on Gastro-intestinal Sensitivity of Patients With Major Depressive Disorder
PHASE4Patients with major depressive disorder (MDD) commonly have many gastrointe...
Location
Hospital Universitari vall d'Hebron
A 14-week, Multi-center Study of [S,S]-Reboxetine in Patients With Fibromyalgia.
PHASE3This is a study to investigate the effectiveness and safety of \[S,S\]-Rebo...
Location
Pfizer Investigational Site